1 February 2018 - Deborah Wilkes
Archived
Stada Arzneimittel has appointed Peter Goldschmidt – a senior executive at Novartis' Sandoz division – as its new permanent chief executive officer. He will be the German generics and OTC company's fifth chief executive officer in around two years.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.